AMPX vs RCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

AMPX

59.9
AI Score
VS
AMPX Wins

RCAT

55.6
AI Score

Investment Advisor Scores

AMPX

60score
Recommendation
BUY

RCAT

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AMPX RCAT Winner
Forward P/E 161.2903 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 125.9% 527.2% RCAT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 59.9/100 55.6/100 AMPX
Profit Margin -33.4% -136.3% AMPX
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD AMPX

Relative Price Performance (Last 90 Days)

AMPX 1M: -16.7% · 3M: -16.1% RCAT 1M: -34.0% · 3M: -43.0%

Current Technical Phase

AMPX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.5%), weak momentum, RSI 41

RSI (14): 40.9 · Price: $8.31

RCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.8%), weak momentum, RSI 21

RSI (14): 20.9 · Price: $4.58

Fundamentals Snapshot

Metric AMPX RCAT
Market Cap — —
Forward P/E 83.1 -15.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 1.3% 5.3%
Gross Margin 0.2% 0.1%
Operating Margin -0.1% -1.9%
EPS -0.29 -0.77
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AMPX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.